The Association Between Uterine Artery Notch and First Trimester Bleeding

First Trimester Bleeding Clinical Trial

Official title:

The Association Between Uterine Artery Notch and First Trimester Bleeding

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01069406
• Other study ID #: sor493710CTIL
• Status: Completed
• Phase: N/A
• First received: February 15, 2010
• Last updated: May 18, 2015
• Start date: March 2010
• Est. completion date: May 2012

Study information

• Verified date: May 2015
• Source: Soroka University Medical Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: Israel: Ethics Commission
• Study type: Observational

Clinical Trial Summary

The purpose of the present study is to evaluate the occurrence of first trimester bleeding among patients with abnormal uterine artery Doppler.

A prospective study is designed and two groups will be studied; patients with abnormal uterine artery Doppler at second trimester (study group) and patient with normal uterine artery Doppler at second trimester (control group).The patients will be asked, as part of the routine history taken before the US about having first trimester bleeding during the current pregnancy.

Description:

The purpose of the present study is to evaluate the occurrence of first trimester bleeding among patients with abnormal uterine artery Doppler.

A prospective study is designed and two groups will be studied; patients with abnormal uterine artery Doppler at second trimester (study group) and patient with normal uterine artery Doppler at second trimester (control group). Both the study group and the control group represent high risk pregnant patients and the Doppler flows are done as part of the patient's predictive risk for placental associated abnormalities. The patients will be asked, as part of the routine history taken before the US about having first trimester bleeding during the current pregnancy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 200
• Est. completion date: May 2012
• Est. primary completion date: May 2012
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patients with abnormal uterine artery Doppler at second trimester

Exclusion Criteria:

• Multi fetal pregnancies

• Patients without known gestational age (according to last month period or first trimester ultrasound

• Pregnancies with congenital structural or chromosomal anomalies

• Lack of prenatal care

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• First Trimester Bleeding
• Hemorrhage
• Uterine Artery Notch

Locations

Country	Name	City	State
Israel	Us unit	Soroka medical center	Beer sheva

Sponsors (1)

Lead Sponsor	Collaborator
Soroka University Medical Center

Country where clinical trial is conducted

Israel,